Taxol resistance

Chemotherapy

Volumn 46, Issue 5, 2000, Pages 327-334

  Sangrajrang, Suleeporn ^a   Fellous, Ariette ^b  

^a NATIONAL CANCER INSTITUTE   (Thailand)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Cancer; Microtubules; Resistance; Taxol

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; TUBULIN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROTUBULE; PRIORITY JOURNAL; PROTEIN PROCESSING; STRUCTURE ACTIVITY RELATION;

EID: 0033802883     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007306     Document Type: Article

References (62)

1. Wani M, Taylor HL, Wall ME, Coggon P, Mcphail AT, Plant antitumor agents. VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxiu brevifolia. J Am Chem Soc 1971;93: 2325-2327.
2. Kohn EC, Sarosy G, Bicher A, Link C, Christian M, Steinberg SM, Rothenberg M, Adamo DO, Davis P, Ognibene FP, Cunnion RE, Reed E, Dose-intense Taxol: High response rate in patients with platinum-resistant recurrent ovarian cancer. J Natl Cancer Inst 1994;86:18-24.
3. Rowinsky EK, Donehower RC, Paclitaxcl (Taxol). N Engl J Med 1995; 332:1004-1014.
4. Rowinsky EK, Onetto N, Canett'a RM, Arbuck SG, Taxol: The first of the taxanes, an important new class of antitumor agents. Semin Oncol 1992;19:646-662.
5. Krauhs E, Little M, Kempf T, Hofer-Warbinek R, Ade W, Ponstingl H, Complete amino acid sequence of -tubulin from porcine brain. Proc Natl Acad Sei USA 1981;78: 4156-4160.
6. Sullivan KF, Cleveland DW, Identification of conserved isotype-defending variable region sequences for four vertebrate tubulin polypcptide classes. Proc Natl Acad Sei USA 1986;83:4237-4331.
7. Raybin D, Flavin M, An enzyme tyrosylation a-tubulin and its role in microtubule assembly. Biochem Biophys Res Commun 1975;65: 1088-1095.
8. Eipper BA, Rat brain microtubule protein: Purification and determination of covalently bound phosphate and carbohydrate. Proc Natl Acad Sei USA 1972;69:2283-2287.
9. Eddc B, Rossier J, Le Caer JP, Desbruyeres E, Gros F, Denoulet P, Glutamylation, a new posttranslation modification of alpha-tubulin. Science 1990;247:83-85.
10. Olmsted JB, Non-motor microtubule-associated proteins. Curr Opin CellBioll991;3:52-58.
11. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW, A protein factor essential for microtubule assembly. Proc Natl Acad Sei USA 1975;72:1858-I862.
12. Slobada RD, Rudolph SA, Rosenbaum JL, Greengard P, Cyclic AMP-dependent endogenous phosphorylation of a microtubule-associated protein. Proc Natl Acad Sei USA1975;72:177-181.
13. Olmsted JB, Lyon HD, A microtubule-associated protein specific to differentiated neuroblastoma cells. J Biol Chem 1981;256:3507-3511.
14. ManfrediJJ, ParnessJ.HorwiztSB: Taxol bind to cellular microtubules. J Cell Biol 1982;94:688-696.
15. Parekh HK, Simpkins H, Speciesspecific differences in Taxol transport and cytotoxicity against human and rodent tumor cells. Evidence for an alternate transport system? Biochem Pharmacol 1996;51:301-311.
16. Horwitz SB, CohenD.RaoS, Ringel I, Shen HJ, Yang CP: Taxol: Mechanism of resistance. Mon Natl Cancer Inst 1993;15:55-61.
17. Jordan MA, Toso RJ, Thrower D, Wilson L, Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc Natl Acad Sei 1993;90: 9552-9556.
18. Rao S, Orr GA, Chaudhary AG, Kingston DGI, Horwitz SA, Characterization of the Taxol binding site on the microtubule. J Biol Chem 1995;270:20235-20238.
19. Combeau C, Commercon A, Mioskowki C, Predominant labeling of beta- over alpha-tubulin porcine brain by a photoactivatable taxoid derivative. Biochemistry 1994;33: 6676-6683.
20. Paress J, Horwitz SB, Taxol binds to polymerized tubulin in vitro. J Cell Bioll 981;91:479-487.
21. Ding A, Porteu F, Sanchez E, Nathan CF, Shared actions of endotoxin and Taxol on TNF receptors and TNF release. Science 1990;248: 370-372.
22. Manthey CL, Brandes ME, Perera PY, Vogel SN, Taxol increases the steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphory'ation in murine macrophage. J Immunol 1992;149:2459-2465.
23. O'Brien JM Jr, Wewers MD, Moore SA, Allen JN, Taxol and colchicine increase LPS-induced pro-IL-1 beta production, but do not increase IL-1 beta secretion. A role for microtubules in the regulation of IL-1 beta production. J Immunol 1995;158: 4113-4122.
24. Rosette C, Karin M, Cytoskeletal control of gene expression: Depolymerization of microtubules activates NF-kappa B. J Cell Biol 1995; 128:1111-1119.
25. Blagosklonny MV, Schulte TW, Nguyen P, Mimnaugh EG, Trepcl J, Neckers L, Taxol induction of p21\vafl and p53 requires c-raf-1. Cancer Res 1995;55:4623-4626.
26. Bradley G, Ling V, P-glycoprotein, multidrug resistance and tumor progression. Metastasis Rev 1994;13: 223-233.
27. Gotterman MM, Pastan I, Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385427.
28. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquis KC, Stewart AJ, Kruz EU, Duncan AM, Deeley RG, Overexpression of a transport gene in a multidrug resistant human lung cancer cell line. Science 1992;258:1650-1654.
29. Jedlitschky G, Leier I, Buchholz U, Barnounin K, Kruz G, Kepper D, Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 1996;56: 988-994.
30. Breuninger LM, Paul S, Gaughan K, Miki T, Chan A, Aaronson SA, Kruh GD, Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res 1995; 55:5342-5347.
31. Cole SPC, Sparks KE, Fraser K, Pharmacological characterization of multidrug-resistant MRPtransfected human tumor cell. Can' cerRes!994;54:5902-5910.
32. Lewis SA, Cowan NJ, Tubulin genes: Structure, expression and regulation; in Avia J (ed): Microtubule Protein. Boca Raton, CRC Press, 1990, pp 37-66.
33. Kavallaris M, Kuo DY, Burkhart CA, Regl DL, Norris MD, Haber M, Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific -tubulin isotypes. J Clin Invest 1997;100:12821293.
34. Giannakaku P, Sackette DL, Kang YK, Zhan Z, Butler JTM, Fojo T, Poruchynsky S, Paclitaxel-rcsistant human ovarian cancer cells have mutant -tubulin that exhibit impaired paclitaxel-derived polymerization. J Biol Chem 1997;27: 17118-17125.
35. Ranganathan S, Benetatos CA, Colarusso PJ, Hudes GR, Altered tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells. Br J Cancer 1998;77: 562-566.
36. Jaffrézou JP, Dumontet C, Derry B, Daran G, Chcn G, Tsuchiya E, Wilson L, Jordan MA, Sikic BI, Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833. Oncol Res 1995;7:517527.
37. Dumotet C, Duran GE, Sieger KA, Beketic-Oreskovic L, Sikic B, Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel. Cancer Res 1996;56:1091-1097.
38. OhtaS,NishioK,KubotaN,Ohmori T, Funayama Y, Ohira T, Nakajima H, Adachi M, Saijo N, Characterization of a Taxol-resistant human small-cell lung cancer cell line. JpnJ Cancer Res I994;85:290-297.
39. Panda D, Miller HP, Banerjee A, Luduena RF, Wilson L, Microtubule dynamics in vitro are regulated by the tubulin isotype composition. Proc Nail Acad Sei USA 1994;91: 11358-11362.
40. Derry WB, Wilson L, Jordan MA, Substoichiometric binding of Taxol suppresses microtubule dynamics. Biochemistry 1995;34:2203-22I1.
41. Kavallaris M, Burkhart CA, Horwitz SB, Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol. Br J Cancer 1999;80:1020-1025.
42. Audebert S, Desbruyères E, Gruszczynski C, Koulakoff A, Gros F, Edde B, Reversible polyglutamylation of a- and -tubulin and microtubule dynamics in mouse brain neurons. Mol Biol Cell 1993;4:615-626.
43. Boucher D, LarcherJC, Gros F, Denoulet P, Polyglutamylation of tubulin as a progressive regulator of in vitro interactions between the microtubule-associated protein Tau and tubulin. Biochemistry 1994;33: 12471-12477.
44. Larcher JC, Boucher D, Lazereg S, Gros F, Denoulet P, Interaction of kinesin motor domains a- and tubulin subunits at a Tau-independent binding site: Regulation by polyglutamylation. ' J Biol Chem 1996;271:22 II7-22124.
45. Sangrajrang S, Denoulet P, Laing NM, Tatoud R, Millot M, Calvo F, Tew KD, Fellous A, Association of estramustine resistance in human prostatic carcinoma cells with modified patterns of tubulin expression. Biochem Pharmacol 1998;55:325331.
46. ZhangCC, Yang JM, White E, Murphy M, Levine A, Hait WN, The role of M AP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloid in p53 mutant cells. Oncogene 1998;16:16171624.
47. Frames Y, Gounon P, Veitia R, Bissery MC, Felluos A, Influence of microtubule-associated proteins on the differential effects of paclitaxel and docetaxel. J Protein Chem 1996; 15: 377-388.
48. White E, Life, death and the pursuit of apoptosis. Genes Dev 1996;10:l15.
49. Lanni JS, Lowe SW, Licitra EJ, Liu JO, Jacks T: p53-independent apoptosis induced by paclitaxel through an indirect mechanism. Proc Natl Acad Sei USA I997;94:9679-9683.
50. Rosell R, Gonzalez-Larriba JL, Alberola V, Molina F, Monzo M, Benito D, Ferez JM, de Anta JM, Singleagent paclitaxel by a 3-hour infusion in the treatment of non-small cell lung cancer: Links between p53 and K-ras gene status and chemoscnsitivity. Semin Oncol 1995;22(6 suppl 14):12-18.
51. Wahl AF, Donaldson KL, Fairchild C, Lee FY, Foster SA, Demers GW, Galloway DA, Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med 1996;2:7279.
52. Tang C, Willingham MC, Reed JC Miyashita T, Ray S, Ponnathpur Y, Mahoney ME, Bullock G, Bhalla K, High levels of p26BCl-2-oncoprotein retard Taxol-induced apoptosis in human pre-B leukemia cells. Leukemia 1994;8:1960-1969.
53. Sumantran VN, Ealovega MYV, Nunez G, Clarks MF, Wicha MS, Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced in vivo and in vitro. Cancer Resl995;55:2507-2510.
54. McDonnelle TJ, Troncoso P, Brisbay SM, Logothesis C, Chung LWK, Hseieh JT, Tu SM, Campell ML, Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgenindependent prostate cancer. Cancer Res 1992;52:6940-6944.
55. Hudes GR, Nathan FE, Khater C, Haas N, Cornfield M, Giantonio B, Greemberg R, Gomella L, Litwins S, Ross E, Roetmke S, McAleer C, Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone refractory prostate cancer. J Clin Oncol 1997; 15: 3156-3163.
56. Vogt HG, Kolotas C, Martin T, Schneider LV, Neeb A, Mitrou PS, Diergarten K, Dornoff W, Zambo-. glou N: Simultaneous radiotherapy with paclitaxel in non-small cell lung cancer: A clinical phase I study. Scmin Oncol 1996;23(6 suppl 15): 26-30.
57. Wehbe T, Glantz M, Choy H, Glantz L, Cortez S, Akerley W, Mills P, Cole B, Histologie evidence of a radiosensitizing effect of Taxol in patients with astrocytomas. J Neurooncoll998;39:245-251.
58. Vogt HG, Martin T, Schneider L, Strassman G, Zamboglou N, Simultaneous paclitaxel and radiotherapy: Initial clinical experience in lung cancer and other malignancies. Semin Oncol 1996;24(4 suppl 12): S12-101-S12-105.
59. Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME, Huang Y, Taxol induced internucleosome DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 1993;7:563-568.
60. Woods CM, Zhu J, McQueney PA, Bollag D, Lazarides E, Taxol induced mitotic block triggers rapid of a p53-indendent apoptotic pathway. MolMedl995;l:506-526.
61. Pulkkinen JO, Pekkola K, Grenman R, Paclitaxel and irradiation induce apoptosis in squamous cell carcinoma cell lines in an additive way. Anticancer Res 1996;16:29232929.
62. Geyp M, Ireland CM, Pittman SM, Resistance to apoptotic cell death in a drug resistant T cell leukemia cell line. Leukemia 1996;10:447-455.